This award celebrates your commitment to sustainable development in the pharmaceutical industry.   The winner of this award will be leading an initiative, whether it's in a single project, across multiple initiatives, or by driving change within your organisation.  It will be moving moves pharma closer to becoming an industry at the forefront of sustainability.   

1. Executive summary of the application – 2000-characters (inc spaces) limit

2. To what extent did the initiative address a sustainability problem?

3. What tangible outcomes are already evident from the initiative?

4. To what extent has the project got a convincing strategy to scale?

5. How successful has this initiative been to date? To what extent will this project have sustained impact?

This award celebrates programmes and projects that have helped to reduce health inequalities and had a positive impact on the health of a social, economic or geographic population. The winner of this award will show clear evidence that a specific health inequality was understood and addressed - and that this had a positive impact on the health of the group and therefore made a contribution to health equity

1. Executive summary of the application – 2000-characters (inc spaces) limit
2. To what extent did the project/initiative identify and understand previously unmet patient needs, prior to and during implementation?
3. To what extent has the candidate gone beyond the normal course of business to enable equitable access?
4. To what extent did the project demonstrate a quantifiable positive impact on access patients in underserved communities?
5. How successful has this initiative been to date? Does the project show demonstrated impact?
6. How sustainable is this initiative? Will long-term impact be created, or will impact be created that goes beyond the initial target issue?

This award celebrated your impact of AI systems in helping to solve challenges across the pharmaceutical industry. The award honours organisations and initiatives leveraging AI to revolutionise patient care, diagnostics, treatment planning, drug discovery, and healthcare delivery. Recipients demonstrate exceptional innovation and impact in improving health outcomes and driving efficiencies within the healthcare ecosystem.

1. Executive summary of the application – 2000-characters (inc spaces) limit
2. To what extent did the initiative address a problem?
3. What tangible outcomes are already evident from the initiative?
4. How successful has this initiative been to date? Does the project show demonstrated impact?

The winner of this award will be the creator of a pharma-pharma or pharma-NGO, Association or Non-profit initiative which clearly brings a new proposition to either HCPs, payers and/or healthcare systems, creates new value and redefines what is possible in our industry with a degree of lateral thinking. There is no limit to the number of participants, however each collaboration must involve at least one biopharmaceutical company. Please indicate in your entry how you were able to leverage the unique qualities of each partner, and how the collaboration has been managed and presented for maximum impact.

1. Executive summary of the application – 2000-characters (inc spaces) limit
2. How well did applicant really understand the needs or wishes of their customer/recipient?
3. How well did the project justify a partnership-driven approach, and harness the specific strengths of different partners in order to deliver on these needs or wishes?
4. How well was the collaboration managed and executed?
5. To what extent did the project demonstrate a quantifiable positive impact on its intended customer?
6. To what extent did the project innovate to create this impact?

This award is for an initiative that has raised the profile and visibility of a disease, cause, health concern, population or treatment. We are not looking to reward mere advertising (no matter how good it is); we are seeking campaigns which have provided additional value, shown creative ways to raise awareness, gathered further reach in an additional way, clarified scientific concepts for HCPs or patients, or made things easier or clearer. Ultimately, we are looking for an authentic effort to educate and further the understanding of something that matters, and that has achieved success in doing so.

1. Executive summary of the application – 2000-characters (inc spaces) limit
2. To what extent did the team manage to define and connect with an underlying unaddressed issue?
3. Once the project was initiated, how would you evaluate the quality of the team’s approach to understand real health requirements prior to implementation?
4. To what extent was a creative approach demonstrated to foster better engagement, learning and understanding?
5. How successful has this initiative been to date? Does the project show demonstrated impact?
6. How sustainable is this initiative? Will long-term impact be created, or will impact be created that goes beyond the initial target issue?

This award is for an original product, product enhancement or invention which has the potential and, ideally, early traction to provide significant impact on a patient population. Perhaps it is a newly launched drug showing strong initial results, a new process showing real promise, or a new category or class of treatment that will redefine standard of care in an area. The winner doesn’t need to demonstrate commercial success, but needs to show that the product has been launched or will be launched imminently, and that it has disruptive potential with identifiable value for patients, caregivers or health professionals. The winner will be a genuine pioneer, bringing something novel and meaningful to the life sciences industry.

1. Executive summary of the application – 2000-characters (inc spaces) limit
2. Please describe the product or invention which could be described as a breakthrough or discovery.
3. Please explain the projected impact of this product or invention, ideally with reference to patient care, societal benefit or health system improvement.
4. What early traction shows that this is likely to have the impact described?
5. Describe why you consider this to be novel and inventive.
6. Please explain how you were able to obtain support, funding or a mandate to work on this.
7. What impact do you believe your initiative will have on future inventions (whether from you, your organisation or the industry at large?)

The winner of this award will be a project, initiative or individual that has advanced patient outreach and engagement, through digital approaches, post launch. It should demonstrate an iterative approach to product development by identifying and addressing real health requirements prior to and during implementation. The winning project or candidate will have met a strong patient need and been managed to an outstanding level, making a quantifiable, positive impact on patients.

1. Executive summary of the application – 2000-characters (inc spaces) limit
2. To what extent has the candidate or project gone beyond the normal course of business to make an impact on the lives of patients?
3. How well has the candidate or project managed to overcome any challenges that they may have been faced with?
4. How well does the candidate or project exhibit general leadership qualities or principles that include patient value, healthcare influence, education/awareness and commercial benefits for pharma?
5. To what extent did the actions of the nominee/project create positive change for patients, and/or caregivers? What is the scale of impact?
6. How sustainable is the impact of the actions that the candidate or project has taken to create positive change for patients, and/or caregivers?